| Literature DB >> 27610153 |
Kangkang Zhi1, Zhongduo Yang1, Jie Sheng1, Zongmei Shu1, Yin Shi2.
Abstract
To develop a new more accurate spectrophotometric method for detecting monoamine oxidase inhibitors from plant extracts, a series of amine substrates were selected and their ability to be oxidized by monoamine oxidase was evaluated by the HPLC method and a new substrate was used to develop a peroxidase-linked spectrophotometric assay. 4-(Trifluoromethyl) benzylamine (11) was proved to be an excellent substrate for peroxidase-linked spectrophotometric assay. Therefore, a new peroxidase-linked spectrophotometric assay was set up. The principle of the method is that the MAO converts 11 into aldehyde, ammonia and hydrogen peroxide. In the presence of peroxidase, the hydrogen peroxide will oxidize 4-aminoantipyrine into oxidised 4-aminoantipyrine which can condense with vanillic acid to give a red quinoneimine dye. The production of the quinoneimine dye was detected at 490 nm by a microplate reader. The ⊿OD value between the blank group and blank negative control group in this new method is twice as much as that in Holt's method, which enables the procedure to be more accurate and avoids the produce of false positive results. The new method will be helpful for researchers to screening monoamine oxidase inhibitors from deep-color plant extracts.Entities:
Keywords: Amine substrate; HPLC; Monoamine oxidase inhibitors; Spectrophotometric Assay
Year: 2016 PMID: 27610153 PMCID: PMC4986129
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Scheme 1Scheme for peroxidase-linked spectrophotometric monoamine oxidase (MAO) inhibitor assay modified from Holt et al
Information of the candidate substrates and their oxidation yield by MAO
|
|
|
|
|
| |
|---|---|---|---|---|---|
| 1 | Tryptamine hydrochloride (98%) | 343-94-2 | 280 nm | 24.93% | |
| 2 | Tyramine (98%) | 51-67-2 | 274 nm | 39.43% | |
| 3 | 2-Thiopheneethylamine (98%) | 30433-91-1 | 233 nm | - | |
| 4 | 4-Hydroxy-3-methoxybenzylamine hydrochloride (99%) | 7149-10-2 | 279 nm | 45.91% | |
| 5 | 3, 4-Dimethoxyphenethylamine (%) | 120-20-7 | 278 nm | 14.03% | |
| 6 | 4-Methoxyphenethylamine (97%) | 55-81-2 | 275 nm | 0.00% | |
| 7 | 1-Naphthylmethylamine (98%) | 118-31-0 | 280 nm | 49.50% | |
| 8 | 3-Phenyl-1-propylamine (98%) | 2038-57-5 | 257 nm | 30.89% | |
| 9 | 4-Fluorobenzylamine (99%) | 140-75-0 | 262 nm | 19.92% | |
| 10 | 2-(p-Tolyl) ethylamine (97%) | 3261-62-9 | 263 nm | 11.01% | |
| 11 | 4-(Trifluoromethyl) benzylamine (98%) | 3300-51-4 | 262 nm | 98.80% | |
| 12 | Furfurylamine (99%) | 617-89-0 | 276 nm | - | |
| 13 | 2-Phenethylamine (98%) | 64-04-0 | 257 nm | 24.77% | |
| 14 | 3-Methoxybenzylamine (98%) | 5071-96-5 | 273 nm | 74.27% | |
| 15 | 4-Nitroaniline (99%) | 100-01-6 | 383 nm | 0.00% | |
| 16 | 2-Chlorobenzylamine (98%) | 89-97-4 | 266 nm | 13.74% | |
| 17 | 3-Hydroxy-4-methoxyphenethylamine hydrochloride (99%) | 645-33-0 | 279 nm | 55.65% | |
| 18 | 3-(Trifluoromethyl) benzylamine (98%) | 2740-83-2 | 262 nm | 87.88% | |
| 19 | 2-(Trifluoromethyl) benzylamine (98%) | 3048-01-9 | 262 nm | 14.94% | |
| 20 | 2-Methoxybenzylamine (97%) | 6850-57-3 | 273 nm | 10.97% | |
| 21 | 4-Methoxybenzylamine (98%) | 2393-23-9 | 272 nm | 86.30% | |
| 22 | Benzylamine (99%) | 100-46-9 | 256 nm | 43.66% | |
| 23 | N-Benzylmethylamine (97%) | 103-67-3 | 256 nm | 28.70% | |
| 24 | N, N-Dimethylbenzylamine (99%) | 103-83-3 | 261 nm | 0.00% | |
| 25 | 2-Fluorobenzylamine (98%) | 89-99-6 | 262 nm | 32.09% | |
| 26 | 2-Bromobenzylamine (98%) | 3959-05-5 | 267 nm | 0.00% |
Figure 1Adding TEA to the mobile phase improves peak shape. A: no TEA B: TEA was adding to mobile phase
⊿OD values of substrates 2, 4, 7, 11, 14, 17, 18, 21 and 22.
|
|
|
|---|---|
| 2 (used in Holt’s method) | 0.198±0.004 |
| 4 | 0.052±0.002 |
| 7 | 0.216±0.003 |
| 11 | 0.425±0.003 |
| 14 | 0.273±0.004 |
| 17 | 0.033±0.003 |
| 18 | 0.284±0.002 |
| 21 | 0.278±0.005 |
| 22 | 0.306±0.003 |
Figure 2The effect of enzyme solutions concentration on the ⊿OD, as assayed by the spectrophotometric assay. A: for Total MAO; B: for MAO-A (add pargyline to inhibit MAO-B); C: for MAO-B (add clorgyline to inhibit MAO-A).
Figure 3Inhibitory curve of three known inhibitors against MAO. A: iproniazid against total MAO; B: clorgyline against MAO-A; C: pargyline against MAO-B